Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use: Guidance for Industry and Food and Drug Administration Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 20, 2020
July 21, 2020
29251db7-6c74-4d63-affc-a906cc2d1efa
Related Documents
Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentDecember 18, 2025Center for Devices and Radiological Health
Testing for Biotin Interference in In Vitro Diagnostic Devices: Guidance for Industry
Guidance DocumentOctober 16, 2020Center for Biologics Evaluation and Research
Evaluation of Devices Used with Regenerative Medicine Advanced Therapies: Guidance for Industry
Guidance DocumentFebruary 15, 2019Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.